Renin Available to Researchers at Lee Biosolutions

ST. LOUIS – Clinical researchers can purchase recombinant and native human Renin online from biomaterials provider Lee Biosolutions, at www.leebio.com.

Renin is a key enzyme produced and released by the kidneys which initiates a cascade of reactions leading to the formation of Angiotensin II, which helps control sodium-potassium balance, fluid volume and blood pressure in the body. It plays a critical role in the diagnosis and treatment of a variety of conditions including hypertension, cirrhosis, renal tumors, Addison’s disease, and Conn’s syndrome.

“We first began offering Renin to clinical researchers in the spring of 2005,” Lee Biosolutions President Burton Lee said. “After a 10-year depletion of all known supplies of the enzyme, we recognized a revitalization in Renin-based research and began isolating, purifying and stabilizing the enzyme to meet the new demand.”

Lee Biosolutions offers human Renin derived from human kidneys, as well as lab created recombinant Renin. Donors for the native product are of US origin and have been tested and found negative for HbsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen by currently approved FDA methods.

Novartis Pharmaceuticals announced the first daily-dose renin inhibitor to treat hypertension and improve organ protection in March 2005. Since then, Renin-based research has taken off and become the focus of numerous clinical studies.

Lee Biosolutions is a leader in the biomaterials industry, providing the quality biomaterial products to clinical labs and researchers around the world, developing tomorrow’s cures. The company has provided the materials used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s newly redesigned website, www.leebio.com.